U.S. Professional Services Stock News

The Digi International Inc. ( NASDAQ:DGII ) share price has done very well over the last month, posting an excellent...

Capital Southwest Corporation recently announced it had promoted Grant Eason, a 15-year credit underwriting veteran with nearly seven years at the firm, to Managing Director, highlighting continuity in its middle-market lending leadership. This leadership expansion coincides with revenue growth, a strong earnings outlook, ongoing insider share purchases, and affirmed plus special dividends that collectively reinforce investor focus on Capital Southwest’s execution and capital return...

Rogers (ROG) is back on investors’ radar after a stretch of weakening fundamentals, with customers delaying orders, revenue sliding about 7% a year, and profitability metrics trending the wrong way. See our latest analysis for Rogers. Even with fundamentals under pressure, Rogers' latest share price of $87.39 and a roughly 4% 3 month share price return suggest sentiment has stabilized a bit. However, the roughly 18% 1 year total shareholder return loss shows long term momentum is still...

Globant (NYSE:GLOB) just released its Tech Trends 2026 report, laying out five big forces it thinks will steer enterprise AI. For investors, this is less about buzz and more about strategy signaling. See our latest analysis for Globant. The report lands after a tough stretch, with Globant’s share price down sharply on a one year total shareholder return basis. However, the recent 3 month share price return suggests some momentum is creeping back in as investors reassess its AI positioning. If...

Full Truck Alliance (YMM) just posted its Q3 earnings, delivering roughly 11% revenue growth and sharp gains in core transaction services, while also buying a majority stake in Giga.AI to deepen its logistics focused AI stack. See our latest analysis for Full Truck Alliance. The Q3 beat and Giga.AI deal land at an interesting moment, with the share price at $11.47 after a weak 3 month share price return but a much stronger 3 year total shareholder return, suggesting the long term story is...

As the United States market remains mixed ahead of a highly anticipated Federal Reserve decision on interest rates, investors are keenly observing how these shifts might impact stock valuations. In this environment, identifying stocks that may be priced below their intrinsic value can offer opportunities for those looking to capitalize on potential market inefficiencies.

Major stock indexes in the United States are currently exhibiting mixed performance as investors await the Federal Reserve's decision on interest rates, which could significantly impact market dynamics. In this context, penny stocks—an older term for shares of smaller or less-established companies—remain a relevant area for exploration. By focusing on those with strong financials and potential growth trajectories, investors can uncover opportunities that might offer both stability and upside...

As the Federal Reserve's anticipated rate cut looms, the U.S. stock market presents a mixed picture with major indices showing varied performances. Amidst this backdrop, small-cap stocks have gained attention for their potential to outperform in a declining interest-rate environment, offering investors opportunities to uncover lesser-known companies poised for growth. In such conditions, identifying stocks with strong fundamentals and resilience becomes crucial for those seeking undiscovered...

As the U.S. market navigates mixed signals ahead of a crucial Federal Reserve decision on interest rates, investors are keenly observing how these changes might impact their portfolios. In such an environment, dividend stocks can offer a stable income stream and potential for growth, making them a valuable consideration for those looking to enhance their investment strategy amidst fluctuating economic conditions.

Yext (YEXT) has just posted its Q3 2026 numbers, with revenue of about $112 million and basic EPS of roughly $0.05 as the company continues to build on the profitability it achieved over the last year. The company has seen quarterly revenue hover around the low $100 million mark over recent periods, from $113.1 million in Q4 2025 to $109.5 million in Q1 2026 and $113.1 million in Q2 2026. EPS has swung from a loss of about $0.06 in Q4 2025 to positive $0.22 in Q2 2026 and stayed in the black...

Fidelity National Information Services (FIS) just delivered an earnings beat, raised its full year revenue and EBITDA guidance, and boosted its share buyback plans, a combination that usually forces investors to revisit the stock. See our latest analysis for Fidelity National Information Services. Even with the upbeat guidance and larger buyback, sentiment is still resetting. The share price is $65.17 and the year to date share price return is negative 18.63 percent, reinforcing a longer term...

Organon (OGN) has been quietly grinding through a rough stretch, with the share price slipping over the past month and past 3 months, so investors are asking whether the downside now reflects opportunity. See our latest analysis for Organon. With the share price now at $6.95 and a steep year to date share price return decline, sentiment clearly shifted. However, the three year total shareholder return slide suggests this has been a long, grinding de rating rather than a sudden shock. If...

Concentra Group Holdings Parent recently opened Concentra Corona, a new occupational health medical center at 629 North Main Street, Unit C-3, Corona, California, offering work injury care, physical therapy, drug testing, DOT physicals, pre-placement exams, and employer-focused telemedicine services. This expansion deepens Concentra’s California footprint and highlights how its proprietary Concentra Telemed platform is being integrated alongside brick‑and‑mortar clinics to support employer...

If you are wondering whether PNC Financial Services Group at around $202 a share is still good value, or if the easy gains are already behind it, you are not alone. That is exactly what this breakdown is here to unpack. The stock has climbed 2.1% over the last week and 9.2% in the past month, building on a 52.5% gain over three years and 66.7% over five years. This naturally raises the question of how much upside might be left. Recent moves have been shaped by a steadier outlook for interest...

If you are wondering whether Alphatec Holdings at around $20.67 is still a smart buy after its huge run, or if the easy money has already been made, you are not alone. The stock has slipped 2.6% over the last week but is still up 2.1% over 30 days, with an eye catching 128.1% gain year to date and 113.3% over the past year. This naturally raises questions about how much upside is left. Investors have been reacting to a stream of positive updates around Alphatec's expanding spine surgery...

In early December 2025, BioNTech and its partners OncoC4 and Bristol Myers Squibb reported past trial data showing that their experimental cancer therapies gotistobart and pumitamig improved outcomes versus standard care in difficult-to-treat lung and triple-negative breast cancers, with manageable safety profiles and ongoing Phase 3 programs. These oncology readouts suggest BioNTech’s pipeline is starting to yield clinically meaningful assets in high-need solid tumors, potentially...

Frontline plc’s 2025 Annual General Meeting on 8 December 2025 approved Richard C. Prince as a new director and backed wide share issuance authority, following the US$290 million sale of its five oldest VLCCs and fleet growth to 84 vessels after acquiring 24 VLCCs from Euronav. This combination of board refresh and large-scale asset rotation highlights Frontline’s move toward a younger, more flexible tanker fleet that could influence capital allocation choices. Next, we’ll explore how...

Wondering if Abercrombie & Fitch is still a bargain after its big run, or if the easy money has already been made? You are not alone; this stock has been firmly on value hunters' radars. Despite slipping about 0.2% over the last week, the share price has surged roughly 39.7% in the past month. Longer term returns are mixed, with a 332.5% gain over 3 years but a 27.7% drop over the last year. Recently, the market has been reacting to Abercrombie & Fitch's ongoing brand reinvention and...

If you have been wondering whether Popular is still a buy after its big multi year run, you are not alone. This article will walk through what the current share price is really baking in. The stock has slipped about 0.6% over the last week but remains up 1.0% over the past month, with a strong 25.7% gain year to date and a hefty 142.7% return over five years that suggests the market has steadily been repricing its prospects. Recent headlines have focused on Popular's positioning in Puerto...

If you have been wondering whether Concentrix is a beaten down bargain or a value trap, you are not alone. This article will walk through the numbers in plain English. The stock has bounced recently, up 3.2% over the last week and 10.4% over the past month, even though it is still down 12.5% year to date and 11.3% over the last year. Over a longer horizon, it has seen a much steeper 67.8% slide over three years and 59.0% over five. That kind of whiplash performance has been shaped by...

Wondering if Antero Midstream is still a good buy after its run up, or if most of the easy money has already been made? In this article, we break down what the market is really pricing in here. The stock has climbed to around $18.58, delivering roughly 4.6% over the last week, 4.9% over the past month, 20.0% year to date and 30.5% over the last year, with a 109.6% gain over three years and 235.0% over five years. Those moves have come as midstream energy names like Antero have benefited from...

Wondering if SLM is quietly trading below what it is really worth? You are not alone. This stock has been catching the eye of investors hunting for mispriced financial names. Despite a choppy ride in the short term, with the share price down 12.8% over the last week and 4.1% year to date, the longer term story still shows gains of 68.1% over 3 years and 138.6% over 5 years. Recent market moves have come as investors reassess student loan and consumer credit exposure in a higher rate...

CNH Industrial (NYSE:CNH) is back in focus after two fresh partnership moves, pairing with CHC Navigation on high precision guidance kits and deepening its Cyient alliance around autonomous construction systems. See our latest analysis for CNH Industrial. Those autonomy and precision upgrades come against a tougher market backdrop, with a 90 day share price return of minus 16.7 percent and a one year total shareholder return of minus 20.9 percent, suggesting sentiment has weakened even as CNH...

Clover Health Investments recently reported winning new contracts, supported by an average 10.3% increase in its customer base over the past two years. Earnings per share have compounded at a very large annual rate while cash burn has steadily reduced, pointing to improving operational self-sufficiency. Now we’ll explore how these contract wins and improving earnings quality might reshape Clover Health’s existing technology-focused investment narrative. Trump has pledged to "unleash"...